These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7188940)

  • 1. In vitro heterogeneous degradation of poly(n-alkyl alpha-cyanoacrylates).
    Vezin WR; Florence AT
    J Biomed Mater Res; 1980 Mar; 14(2):93-106. PubMed ID: 7188940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint effects of monomer and stabilizer concentrations on physico-chemical characteristics of poly(butyl 2-cyanoacrylate) nanoparticles.
    Alonso MJ; Sanchez A; Torres D; Seijo B; Vila-Jato JL
    J Microencapsul; 1990; 7(4):517-26. PubMed ID: 1702468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules.
    Rollot JM; Couvreur P; Roblot-Treupel L; Puisieux F
    J Pharm Sci; 1986 Apr; 75(4):361-4. PubMed ID: 3723356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow release polymer-drug systems obtained by moisture promoted polyreactions. 1. Codeine resinate encapsulated in poly(alkyl alpha-cyanoacrylates).
    Lukaszczyk J; Urbaś P
    J Microencapsul; 1998; 15(5):609-20. PubMed ID: 9743916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosize poly(ethylcyanoacrylate) microspheres: preparation and degradation properties.
    Tuncel A; Ciçek H; Hayran M; Pişkin E
    J Biomed Mater Res; 1995 Jun; 29(6):721-8. PubMed ID: 7593009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monolayer studies on poly(isobutylcyanoacrylate)-ampicillin association.
    Baszkin A; Couvreur P; Deyme M; Henry-Michelland S; Albrecht G
    J Pharm Pharmacol; 1987 Dec; 39(12):973-7. PubMed ID: 2894444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro model for the degradation of alkylcyanoacrylate nanoparticles.
    Müller RH; Lherm C; Herbort J; Couvreur P
    Biomaterials; 1990 Oct; 11(8):590-5. PubMed ID: 2279061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption of beta-blockers onto polyisobutylcyanoacrylate nanoparticles measured by depletion and dielectric methods.
    Benoit E; Prot O; Maincent P; Bessière J
    Pharm Res; 1994 Apr; 11(4):585-8. PubMed ID: 7914695
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the hard dental tissue-polymer interface. IV. Studies on the chemical reaction between the mineral substances of hard dental tissues and alkyl-2-cyanoacrylates].
    Alexieva K
    Stomatologiia (Sofiia); 1983; 65(5):38-41. PubMed ID: 6593943
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles.
    Das SK; Tucker IG; Hill DJ; Ganguly N
    Pharm Res; 1995 Apr; 12(4):534-40. PubMed ID: 7596988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfacial properties of polymethyl alpha-cyanoacrylate and polybutyl alpha-cyanoacrylate.
    Florence AT; Haq ME; Johnson JR
    J Pharm Pharmacol; 1976 Jul; 28(7):539-43. PubMed ID: 8604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of polyalkylcyanoacrylate nanoparticles as a potential drug carrier: preparation, morphological characterization and loading capacity.
    Puglisi G; Giammona G; Fresta M; Carlisi B; Micali N; Villari A
    J Microencapsul; 1993; 10(3):353-66. PubMed ID: 8377093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants.
    Kreuter J; Liehl E; Berg U; Soliva M; Speiser PP
    Vaccine; 1988 Jun; 6(3):253-6. PubMed ID: 3420974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface pressure-area isotherms of mixed cyclosporin-poly(isobutylcyanoacrylate) monolayers spread at the air/water interface.
    Miñones J; Yebra-Pimentel E; Conde O; Iribarnegaray E; Casas Parada M; Vila Jato JL; Seijo B
    J Pharm Sci; 1995 Apr; 84(4):508-11. PubMed ID: 7629746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study.
    Arias JL; Ruiz MA; López-Viota M; Delgado AV
    Colloids Surf B Biointerfaces; 2008 Mar; 62(1):64-70. PubMed ID: 17961994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability profile of poly(alkyl cyanoacrylate) nanocapsules.
    Erdmann C; Mayer C
    J Colloid Interface Sci; 2016 Sep; 478():394-401. PubMed ID: 27343463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting.
    Arias JL; Gallardo V; Ruiz MA; Delgado AV
    Eur J Pharm Biopharm; 2008 May; 69(1):54-63. PubMed ID: 18164927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of synthesis and investigation of properties for 2-cyanoacrylates.
    Tseng YC; Hyon SH; Ikada Y
    Biomaterials; 1990 Jan; 11(1):73-9. PubMed ID: 2302452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-controlled, polymer-mediated assembly of polymer micelle nanoparticles.
    Lee SC; Lee HJ
    Langmuir; 2007 Jan; 23(2):488-95. PubMed ID: 17209598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation and drug release characteristics of monosize polyethylcyanoacrylate microspheres.
    Ciçek H; Tuncel A; Tuncel M; Pişkin E
    J Biomater Sci Polym Ed; 1995; 6(9):845-56. PubMed ID: 7772571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.